Errata (DOI:10.1053/j.ajkd.2008.07.040);Association of the Q121 Variant of ENPP1 Gene With Decreased Kidney Function Among Patients With Type 2 Diabetes

American Journal of Kidney Diseases

Volumn 53, Issue 2, 2009, Pages 273-280

  De Cosmo, Salvatore ^a   Minenna, Antonio ^a   Zhang, Yuan Yuan ^b   Thompson, Robert ^b   Miscio, Giuseppe ^a   Vedovato, Monica ^c   Rauseo, Anna ^a   Saller, Alois ^c   Mastroianno, Sandra ^a   Pellegrini, Fabio ^a,d   Trevisan, Roberto ^e   Fioretto, Paola ^c   Doria, Alessandro ^b   Trischitta, Vincenzo ^a,f  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b JOSLIN DIABETES CENTER   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d University of Padova ^*  (Italy)

^e OSPEDALI RIUNITI   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Gene polymorphism; insulin resistance; PC 1; vascular diabetic complications

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 GENE; FEMALE; GENE; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; ITALY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN URINE LEVEL; UNITED STATES;

EID: 58349107086     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.01.006     Document Type: Erratum

References (47)

1. He J., and Whelton P.K. Epidemiology of end-stage renal disease. In: Brenner B.M., and Kurokawa K. (Eds). International Handbook of Renal Disease (1999), Euromed Communications, Haslemere, UK 1-14
2. Muntner P., He J., Hamm L., Loria C., and Whelton P.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13 (2002) 745-753
3. Foley R.N., Parfrey P.S., and Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 suppl 3 (1998) S112-S119
4. Langefeld C.D., Beck S.R., Bowden D.W., et al. Heritability of GFR and albumin in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 43 (2004) 796-800
5. Placha G., Poznik G.D., Dunn J., et al. A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes. Diabetes 55 (2006) 3358-3365
6. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167-174
7. De Cosmo S., Trevisan R., Minenna A., et al. Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glomerular filtration rate in patients with type 2. Diabetes Care 29 (2006) 432-434
8. Almind K., Doria A., and Kahn C.R. Putting the genes for type II diabetes on the map. Nat Med 7 (2001) 277-279
9. Maddux B.A., Sbraccia P., Kumakura S., et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373 (1995) 448-451
10. Costanzo B.V., Trischitta V., Di Paola R., et al. The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes 50 (2001) 831-836
11. Pizzuti A., Frittitta L., Argiolas A., et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48 (1999) 1881-1884
12. Frittitta L., Baratta R., Spampinato D., et al. The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance. J Clin Endocrinol Metab 86 (2001) 5888-5891
13. Kubaszek A., Pihlajamaki J., Karhapaa P., Vauhkonen I., and Laakso M. The K121Q polymorphism of the PC-1 gene is associated with insulin resistance but not with dyslipidemia. Diabetes Care 26 (2003) 464-467
14. Abate N., Carulli L., Cabo-Chan A., Chandalia M., Snell P.G., and Grundy S.M. Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab 88 (2003) 5927-5934
15. Gonzalez-Sanchez J.L., Martinez-Larrad M.T., Fernandez-Perez C., Kubaszek A., Laakso M., and Serrano-Rios M. K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population. Obes Res 11 (2003) 603-605
16. Gu H.F., Almgren P., Lindholm E., et al. Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes 49 (2000) 1601-1603
17. McAteer J.B., Prudente S., Bacci S., et al., ENPP1 Consortium. The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: Evidence from an updated meta-analysis in 42,042 subjects. Diabetes 57 (2008) 1125-1130
18. Endler G., Mannhalter C., Sunder-Plassmann H., et al. The K121Q polymorphism in the plasma cell membrane glycoprotein gene predisposes to early myocardial infarction. J Mol Med 80 (2002) 791-795
19. Bacci S., Ludovico O., Prudente S., et al. The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. Diabetes 54 (2005) 3021-3025
20. De Cosmo S., Argiolas A., Miscio G., et al. A PC-1 aminoacid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes 49 (2000) 521-524
21. Canani L.H., Ng D.P., Smiles A., Rogus J.J., Warram J.H., and Krolewski A.S. Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes 51 (2002) 1188-1193
22. Jacobsen P., Grarup N., Tarnow L., Pedersen O., and Parving H.H. PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients. Nephrol Dial Transplant 17 (2002) 1408-1412
23. De Cosmo S., Trevisan R., Della Vestra M., et al. PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates. Diabetes Care 26 (2003) 2898-2902
24. Boonyasrisawat W., Eberle D., Bacci S., et al. Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes. Diabetes 56 (2007) 499-505
25. De Cosmo S., Minenna A., Ludovico O., et al. Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care 28 (2005) 910-915
26. Levey A.S., Greene T., Kusek J.W., and Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A (abstr)
27. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 49 suppl 2 (2007) S1-S180
28. Higgins J.P., Whitehead A., Turner R.M., Omar R.Z., and Thompson S.G. Meta-analysis of continuous outcome data from individual patients. Stat Med 20 (2001) 2219-2241
29. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
30. Murussi M., Gross J.L., and Silveiro S.P. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric type 2 diabetic patients and normal individuals: A 10-year follow-up. J Diabetes Complications 20 (2006) 210-215
31. Gaede P., Tarnow L., Vedel P., Parving H.H., and Pedersen O. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant 19 (2004) 2784-2788
32. Rossing K., Christensen P.K., Hovind P., Tarnowe L., Rossing P., and Parving H.-H. Progression of nephropathy in type 2 diabetic patients. Kidney Int 66 (2004) 1596-1605
33. Retnakaran R., Cull C.A., Thorne K.I., Adler A.I., Holman R.R., and UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55 (2006) 1832-1839
34. Placha G., Canani L.H., Warram J.H., and Krolewski A.S. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 12 (2005) 155-169
35. Fioretto P., Mauer M., Brocco E., et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39 (1996) 1569-1576
36. Bacci S., Menzaghi C., Di Paola R., et al. The ENPP1 Q121 variant plays a role in the susceptibility to increased pulse pressure. Diabetes 57 suppl 3 (2008) S205A abstr
37. Meyre D., Bouatia-Naji N., Tounian A., et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet 37 (2005) 863-867
38. Bochenski J., Placha G., Wanic K., et al. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes 55 (2006) 2626-2630
39. Abate N., Chandalia M., Satija P., et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 54 (2005) 1207-1213
40. Chudleigh R.A., Dunseath G., Evans W., et al. How reliable is estimation of glomerular filtration rate at diagnosis of type 2 diabetes?. Diabetes Care 30 (2007) 300-305
41. Rigalleau V., Lasseur C., Raffaitin C., et al. Normoalbuminuric renal insufficient diabetic patients: A lower risk group. Diabetes Care 30 (2007) 2034-2039
42. Böttcher Y., Körner A., Reinehr T., et al. ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children. J Clin Endocrinol Metab 91 (2006) 4948-4952
43. Bochenski J., Placha G., Wanic K., et al. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes 55 (2006) 2626-2630
44. Lyon H.N., Florez J.C., Bersaglieri T., et al. Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity. Diabetes 55 (2006) 3180-3184
45. Weedon M.N., Shields B., Hitman G., et al. No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians. Diabetes 55 (2006) 3175-3179
46. Meyre D., Bouatia-Naji N., Vatin V., et al. ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study. Diabetologia 50 (2007) 2090-2096
47. Keene K.L., Mychaleckyj J.C., Smith S.G., et al. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) gene with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 57 (2008) 1057-1062